Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kjong-Van Lehmann

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
BMC Genomics|April 19, 2015
Natural variation of gene models in Drosophila melanogasterYerbol Z Kurmangaliyev, Alexander V Favorov, Noha M Osman, et al.
Elife|October 12, 2023
Mutant SF3B1 promotes malignancy in PDACPatrik Simmler, Eleonora I Ioannidi, Tamara Mengis, et al.
Cell|September 7, 2019
A Pan-cancer Transcriptome Analysis Reveals Pervasive Regulation through Alternative PromotersDeniz Demircioğlu, Engin Cukuroglu, Martin Kindermans, et al.
Medrxiv : the Preprint Server for Health Sciences|March 22, 2023
Direct prediction of Homologous Recombination Deficiency from routine histology in ten different tumor types with attention-based Multiple Instance Learning: a development and validation studyChiara Maria Lavinia Loeffler, Omar S M El Nahhas, Hannah Sophie Muti, et al.
BMC Biology|October 8, 2024
Prediction of homologous recombination deficiency from routine histology with attention-based multiple instance learning in nine different tumor typesChiara Maria Lavinia Loeffler, Omar S M El Nahhas, Hannah Sophie Muti, et al.
Blood Advances|December 26, 2023
Collaborative effect of Csnk1a1 haploinsufficiency and mutant p53 in Myc induction can promote leukemic transformationStijn N R Fuchs, Ursula S A Stalmann, Inge A M Snoeren, et al.
Cell Reports|August 24, 2022
SF3B1 facilitates HIF1-signaling and promotes malignancy in pancreatic cancerPatrik Simmler, Cédric Cortijo, Lisa Maria Koch, et al.
Cancer Cell|January 22, 2021
The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision supportAnja Irmisch, Ximena Bonilla, Stéphane Chevrier, et al.
Nature|February 7, 2020
Genomic basis for RNA alterations in cancer, Claudia Calabrese, Natalie R Davidson, et al.
Nature Communications|July 13, 2026
A tumor profiling resource for ovarian cancer: insights into chemotherapy-driven heterogeneity and personalized treatment strategyFrancis Jacob, Rebekka Wegmann, Joanna Ficek-Pascual, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
BMC Genomics|April 19, 2015
Natural variation of gene models in Drosophila melanogasterYerbol Z Kurmangaliyev, Alexander V Favorov, Noha M Osman, et al.
Elife|October 12, 2023
Mutant SF3B1 promotes malignancy in PDACPatrik Simmler, Eleonora I Ioannidi, Tamara Mengis, et al.
Cell|September 7, 2019
A Pan-cancer Transcriptome Analysis Reveals Pervasive Regulation through Alternative PromotersDeniz Demircioğlu, Engin Cukuroglu, Martin Kindermans, et al.
Medrxiv : the Preprint Server for Health Sciences|March 22, 2023
Direct prediction of Homologous Recombination Deficiency from routine histology in ten different tumor types with attention-based Multiple Instance Learning: a development and validation studyChiara Maria Lavinia Loeffler, Omar S M El Nahhas, Hannah Sophie Muti, et al.
BMC Biology|October 8, 2024
Prediction of homologous recombination deficiency from routine histology with attention-based multiple instance learning in nine different tumor typesChiara Maria Lavinia Loeffler, Omar S M El Nahhas, Hannah Sophie Muti, et al.
Blood Advances|December 26, 2023
Collaborative effect of Csnk1a1 haploinsufficiency and mutant p53 in Myc induction can promote leukemic transformationStijn N R Fuchs, Ursula S A Stalmann, Inge A M Snoeren, et al.
Cell Reports|August 24, 2022
SF3B1 facilitates HIF1-signaling and promotes malignancy in pancreatic cancerPatrik Simmler, Cédric Cortijo, Lisa Maria Koch, et al.
Cancer Cell|January 22, 2021
The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision supportAnja Irmisch, Ximena Bonilla, Stéphane Chevrier, et al.
Nature|February 7, 2020
Genomic basis for RNA alterations in cancer, Claudia Calabrese, Natalie R Davidson, et al.
Nature Communications|July 13, 2026
A tumor profiling resource for ovarian cancer: insights into chemotherapy-driven heterogeneity and personalized treatment strategyFrancis Jacob, Rebekka Wegmann, Joanna Ficek-Pascual, et al.
Pageof 3